Domestic drugmakers eye price hike of OTC drugs

Published: 2011-03-14 06:58:00

Updated: 2011-03-14 06:58:00

Korean companies are considering a price hike of their over-the-counter drugs in order to make up for their margins lost by rising import prices, industry sources said recently.

“The faster rise in import prices is attributed to the price hike of OTC products,'' a pharmaceutical official said....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK